Market Performance
ProQR Therapeutics N.V. (NASDAQ:PRQR) surged 5.2% in today's trading, closing at $1.41.
The Healthcare stock traded 802,850 shares, above its average daily volume of 502,752 shares.
big mover upNASDAQ:PRQR
ProQR Therapeutics N.V. (PRQR) Surges 5.2% on Heavy Volume
ProQR Therapeutics N.V. (NASDAQ:PRQR) surged 5.2% in today's trading, closing at $1.41.
At publication ·
What changed
ProQR Therapeutics N.V. (NASDAQ:PRQR) · big mover up
- Price at event
- $1.41
- Price change
- 5.22%
- Average volume to event volume
- 502.8K to 802.9K
- 52-week high
- $2.46
- 52-week low
- $1.22
At a glance
Key takeaways
- ProQR Therapeutics stock closed at $1.41, up 5.2% on above-average trading volume of 802,850 shares.
- The company has a market capitalization of $249.7 million.
- At $1.41, the stock trades near the low end of its 52-week range of $1.22 to $2.46.
- The article does not identify the specific news catalyst driving today's price movement.
Company Overview
ProQR Therapeutics N.V. has a market capitalization of $249.7M. The stock has traded year-to-date.
Sharp single-day moves like this rally in ProQR Therapeutics N.V. are often driven by news catalysts — earnings surprises, analyst actions, sector developments, or broader market conditions. Investors should identify the specific driver before making trading decisions, as the sustainability of the move depends on whether the catalyst changes the fundamental outlook.
ProQR Therapeutics N.V. currently trades at $1.41, positioning the stock at the 15th percentile of its 52-week range ($1.22 — $2.46). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View PRQR Stock Page
Frequently Asked Questions
What is causing PRQR's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our PRQR news page.
What is PRQR's 52-week range?
See full price history and interactive charts on our PRQR chart page.
Loading related coverage…